Hideki Fujii

Active 1986–2026

185
Papers
22,213
Citations
91
h-index
166
i10-index

Citations

Citations per year for Hideki Fujii1977: 1 citations1989: 1 citations1992: 6 citations1993: 3 citations1994: 1 citations1995: 7 citations1996: 10 citations1997: 3 citations1998: 8 citations1999: 6 citations2000: 30 citations2001: 31 citations2002: 45 citations2003: 75 citations2004: 74 citations2005: 79 citations2006: 90 citations2007: 126 citations2008: 124 citations2009: 157 citations2010: 196 citations2011: 192 citations2012: 263 citations2013: 280 citations2014: 277 citations2015: 290 citations2016: 233 citations2017: 209 citations2018: 178 citations2019: 670 citations2020: 786 citations2021: 757 citations2022: 649 citations2023: 454 citations2024: 767 citations2025: 376 citations2026: 10 citations1978–1988: no citations, so these years are not shown1990–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,344 citing papers, 22.5% of this breakdownChina: 1,427 citing papers, 13.7% of this breakdownJapan: 1,151 citing papers, 11.1% of this breakdownGermany: 501 citing papers, 4.8% of this breakdownUnited Kingdom: 496 citing papers, 4.8% of this breakdownItaly: 430 citing papers, 4.1% of this breakdownFrance: 380 citing papers, 3.6% of this breakdownSouth Korea: 287 citing papers, 2.8% of this breakdownCanada: 262 citing papers, 2.5% of this breakdownAustralia: 228 citing papers, 2.2% of this breakdownSpain: 190 citing papers, 1.8% of this breakdownNetherlands: 189 citing papers, 1.8% of this breakdown
0%22.5%Other 24.3%

Fields

  • Medicine61.3%
  • Immunology and Microbiology21.2%
  • Biochemistry, Genetics and Molecular Biology13.3%
  • Neuroscience0.7%
  • Engineering0.7%
  • Dentistry0.5%
  • Other2.3%

Topics

  • Liver Disease Diagnosis and Treatment7.7%
  • Immune Cell Function and Interaction5.3%
  • IL-33, ST2, and ILC Pathways3.7%
  • Immunotherapy and Immune Responses3%
  • Cancer Immunotherapy and Biomarkers2.5%
  • Eosinophilic Esophagitis2.3%
  • Other75.5%

Coauthors

All papers

Open in search
  1. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Qiang Zhu, Mindie H. Nguyen - ˜The œLancet. Gastroenterology & hepatology 2019 cited by 1,051

  2. The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease

    Authors: , , - International Journal of Molecular Sciences 2020 cited by 299

  3. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells

    Authors: , , , , , , , , , - Nature 2009 cited by 1,984

  4. Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Hepatology Communications 2021 cited by 149

  5. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer

    Authors: , , , , , , - International Journal of Cancer 2008 cited by 374

  6. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

    Authors: , , , , , , , , , , , , , , , , , , - BMC Gastroenterology 2012 cited by 385

  7. Porphyromonas gingivalis Outer Membrane Vesicles Stimulate Gingival Epithelial Cells to Induce Pro-Inflammatory Cytokines via the MAPK and STING Pathways

    Authors: , , , , , , , , , - Biomedicines 2022 cited by 48

  8. The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Gastroenterology 2018 cited by 129

  9. Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue - Clinical Gastroenterology and Hepatology 2022 cited by 106

  10. Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice

    Authors: , , , , , , , , , , , , , , - Laboratory Investigation 2021 cited by 53

  11. Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Therapeutic Apheresis and Dialysis 2013 cited by 397

  12. Vitamin D Activates the Nrf2-Keap1 Antioxidant Pathway and Ameliorates Nephropathy in Diabetic Rats

    Authors: , , , , , , , , , - American Journal of Hypertension 2013 cited by 214

  13. The Pathogenic Factors from Oral Streptococci for Systemic Diseases

    Authors: , , , , , , - International Journal of Molecular Sciences 2019 cited by 86

  14. Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery

    Authors: , , , , , , - World Journal of Gastroenterology 2019 cited by 184

  15. Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction

    Authors: , , - Toxins 2018 cited by 135

  16. Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice

    Authors: , , , , , , , - Laboratory Investigation 2010 cited by 130

  17. Optimal Phosphate Control Related to Coronary Artery Calcification in Dialysis Patients

    Authors: , , , , , , , , , - Journal of the American Society of Nephrology 2021 cited by 91

  18. Anti-fibrotic treatments for chronic liver diseases: The present and the future

    Authors: , , , , , - Clinical and Molecular Hepatology 2020 cited by 61

  19. Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Kidney International Reports 2022 cited by 30

  20. Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary Cholangitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yasushi Matsuzaki, Hajime Takikawa, Japan PBC Study Group - Hepatology 2019 cited by 118

  21. Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma

    Authors: , , , , , , , , , - Cancer Research 2012 cited by 217

  22. Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , - BMC Gastroenterology 2020 cited by 60

  23. Role of vitamin E in the treatment of non-alcoholic steatohepatitis

    Authors: , , , , , , , , , - Free Radical Biology and Medicine 2021 cited by 37

  24. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Gastroenterology 2013 cited by 163